RENVELA
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $25,664 | 8 | 1 |
| 2018 | $266.62 | 14 | 14 |
| 2017 | $132,149 | 2,266 | 1,246 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $79,829 | 10 | 50.5% |
| Food and Beverage | $40,183 | 2,244 | 25.4% |
| Travel and Lodging | $27,238 | 24 | 17.2% |
| Unspecified | $5,498 | 7 | 3.5% |
| Consulting Fee | $5,332 | 3 | 3.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease | GENZYME CORPORATION | $5,498 | 7 |
Top Doctors Receiving Payments for RENVELA — Page 50
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Nephrology | Hammond, IN | $11.21 | 1 |
| , MD | Nephrology | Norfolk, VA | $11.19 | 1 |
| , MD | Nephrology | Chicago, IL | $11.19 | 1 |
| , M.D | Nephrology | Evergreen Park, IL | $11.18 | 1 |
| , MD | Specialist | Freeport, NY | $11.13 | 1 |
| , M.D | Internal Medicine | Maywood, IL | $11.08 | 1 |
| , MD | Nephrology | Columbus, OH | $11.05 | 1 |
| , MD | Nephrology | Norfolk, VA | $11.01 | 1 |
| , M.D | Nephrology | Flowood, MS | $10.95 | 1 |
| , M.D | Nephrology | Poland, OH | $10.90 | 1 |
| , M.D | Nephrology | Danville, VA | $10.79 | 1 |
| , M.D | Internal Medicine | Little Rock, AR | $10.78 | 1 |
| , MD | Nephrology | Portsmouth, VA | $10.74 | 1 |
| , MD | Specialist | Euclid, OH | $10.65 | 1 |
| , M.D | Nephrology | Waldorf, MD | $10.61 | 1 |
| , MD | Nephrology | Springfield, OH | $10.61 | 1 |
| , MD, PHD | Internal Medicine | Meridian, ID | $10.59 | 1 |
| , MD | Internal Medicine | Meridian, ID | $10.59 | 1 |
| , MD | Nephrology | Canton, OH | $10.56 | 1 |
| , MD | Nephrology | Tallahassee, FL | $10.56 | 1 |
| , M.D | Nephrology | Woodbridge, VA | $10.55 | 1 |
| , MD | Nephrology | Houston, TX | $10.52 | 1 |
| , M.D | Nephrology | El Paso, TX | $10.45 | 1 |
| , D.O | Nephrology | South Gate, CA | $10.45 | 1 |
| , M.D | Nephrology | Clairton, PA | $10.39 | 1 |
Manufacturing Companies
- SANOFI-AVENTIS U.S. LLC $131,370
- GENZYME CORPORATION $26,710
Product Information
- Type Drug
- Total Payments $158,080
- Total Doctors 1,251
- Transactions 2,288
About RENVELA
RENVELA is a drug associated with $158,080 in payments to 1,251 healthcare providers, recorded across 2,288 transactions in the CMS Open Payments database. The primary manufacturer is SANOFI-AVENTIS U.S. LLC.
Payment data is available from 2017 to 2019. In 2019, $25,664 was paid across 8 transactions to 1 doctors.
The most common payment nature for RENVELA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($79,829, 50.5% of total).
RENVELA is associated with 1 research study, including "Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease" ($5,498).